These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2235142)

  • 1. Serologic evidence of subclinical pertussis in immunized children.
    Long SS; Lischner HW; Deforest A; Clark JL
    Pediatr Infect Dis J; 1990 Oct; 9(10):700-5. PubMed ID: 2235142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical pertussis in incompletely vaccinated and unvaccinated infants.
    Ramkissoon A; Coovadia HM; Loening WE
    S Afr Med J; 1995 Jul; 85(7):662-7. PubMed ID: 7482085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serologic assays for diagnosis of whooping cough.
    Granström G; Wretlind B; Salenstedt CR; Granström M
    J Clin Microbiol; 1988 Sep; 26(9):1818-23. PubMed ID: 2903178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial.
    Hallander HO; Storsaeter J; Möllby R
    J Infect Dis; 1991 May; 163(5):1046-54. PubMed ID: 2019753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
    Zackrisson G; Taranger J; Trollfors B
    J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
    Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
    Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological responses to infection with B. pertussis.
    Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A
    Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.
    Blumberg DA; Mink CM; Cherry JD; Reisinger KS; Blatter MM; Congeni BL; Dekker CL; Stout MG; Mezzatesta JR; Scott JV
    J Pediatr; 1990 Jul; 117(1 Pt 1):46-51. PubMed ID: 2196360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.
    Burstyn DG; Baraff LJ; Peppler MS; Leake RD; St Geme J; Manclark CR
    Infect Immun; 1983 Sep; 41(3):1150-6. PubMed ID: 6309662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pertussis antibody levels in infants immunized with an acellular pertussis component vaccine, measured using whole-cell pertussis ELISA.
    Hanlon M; Nambiar R; Kakakios A; McIntyre P; Land M; Devine P
    Immunol Cell Biol; 2000 Jun; 78(3):254-8. PubMed ID: 10849113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.
    Bernstein HH; Rothstein EP; Pichichero ME; Francis AB; Kovel AJ; Disney FA; Green JL; Marsocci SM; Lynd AM; Wood GC
    Am J Dis Child; 1992 May; 146(5):556-9. PubMed ID: 1621656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of acellular pertussis vaccine in young infants.
    Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
    J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.
    He Q; Viljanen MK; Olander RM; Bogaerts H; De Grave D; Ruuskanen O; Mertsola J
    J Infect Dis; 1994 Sep; 170(3):705-8. PubMed ID: 8077734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
    Syed MA; Ahmed W; Naeem A; Bokhari H
    J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.